INVESTIGADORES
MAZZOLINI RIZZO Guillermo Daniel
artículos
CASADEI, MAILÍN; FIORE, ESTEBAN; RUBIONE, JULIA; DOMÍNGUEZ, LUCIANA MARÍA; CORONEL, MARÍA FLORENCIA; LEIGUARDA, CANDELARIA; GARCÍA, MARIANA; MAZZOLINI, GUILLERMO; VILLAR, MARCELO J.; MONTANER, ALEJANDRO; CONSTANDIL, LUIS; ROMERO-SANDOVAL, E ALFONSO; BRUMOVSKY, PABLO R.
IMT504 blocks allodynia in rats with spared nerve injury by promoting the migration of mesenchymal stem cells and by favoring an anti-inflammatory milieu at the injured nerve
Pain; Año: 2022 vol. 163 p. 1114 - 1129
M. ONORATO, AGOSTINA; FIORE, ESTEBAN; BAYO, JUAN; CASALI, CECILIA; FERNANDEZ-TOMÉ, MARÍA; RODRÍGUEZ, MARCELO; DOMÍNGUEZ, LUCIANA; ARGEMI, JOSEPMARÍA; HIDALGO, FLORENCIA; FAVRE, CRISTIAN; GARCÍA, MARIANA; ATORRASAGASTI, CATALINA; MAZZOLINI, GUILLERMO D.
SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
LIVER INTERNATIONAL; Año: 2021
RODRÍGUEZ, MARCELO M.; ONORATO, AGOSTINA; CANTERO, MARÍA JOSÉ; DOMÍNGUEZ, LUCIANA; BAYO, JUAN; FIORE, ESTEBAN; GARCÍA, MARIANA; ATORRASAGASTI, CATALINA; CANBAY, ALI; MALVICINI, MARIANA; MAZZOLINI, GUILLERMO D.
4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
Scientific Reports; Año: 2021 vol. 11
KUCUKOGLU, OZLEM; SOWA, JAN-PETER; MAZZOLINI, GUILLERMO DANIEL; SYN, WING-KIN; CANBAY, ALI
Hepatokines and adipokines in NASH-related hepatocellular carcinoma
JOURNAL OF HEPATOLOGY; Año: 2021 vol. 74 p. 442 - 457
MAZZOLINI, GUILLERMO; CANBAY, ALI
Alcohol consumption leads to loss of healthy life, but the ADH1B*2 allele may still protect from NASH
Hepatobiliary Surgery and Nutrition; Lugar: Hong Kong; Año: 2021 vol. 10 p. 391 - 393
ATORRASAGASTI, CATALINA; PICCIONI, FLAVIA; BOROWSKI, SOPHIA; TIRADO-GONZÁLEZ, IRENE; FREITAG, NANCY; CANTERO, MARÍA JOSÉ; BAYO, JUAN; MAZZOLINI, GUILLERMO; ALANIZ, LAURA D.; BLOIS, SANDRA M.; GARCIA, MARIANA G.
Acceleration of taa-induced liver fibrosis by stress exposure is associated with upregulation of nerve growth factor and glycopattern deviations
International Journal of Molecular Sciences; Lugar: Basilea; Año: 2021 vol. 22
WEIZ, GISELA; MOLEJON, MARIA I.; MALVICINI, MARIANA; SUKOWATI, CAECILIA H. C.; TIRIBELLI, CLAUDIO; MAZZOLINI, GUILLERMO; BRECCIA, JAVIER D.
Glycosylated 4‐methylumbelliferone as a targeted therapy for hepatocellular carcinoma
LIVER INTERNATIONAL; Año: 2021
CIARLANTINI, MATÍAS S.; BARQUERO, ANDREA; BAYO, JUAN; WETZLER, DIANA; DODES TRAIAN, MARTÍN M.; BUCCI, HERNÁN A.; FIORE, ESTEBAN J.; GANDOLFI DONADÍO, LUCÍA; DEFELIPE, LUCAS; TURJANSKI, ADRIÁN; RAMÍREZ, JAVIER A.; MAZZOLINI, GUILLERMO; COMIN, MARIA J.
Development of an Improved Guanidine-Based Rac1 Inhibitor with in vivo Activity against Non-Small Cell Lung Cancer
CHEMMEDCHEM; Año: 2020
DOMINGUEZ, LUCIANA M.; ESTEBAN FIORE; GUILLERMO MAZZOLINI
Mesenchymal stem/stromal cells. Its therapeutic potential in medicine
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2020
BAYO, JUAN; FIORE, ESTEBAN J.; DOMINGUEZ, LUCIANA MARÍA; CANTERO, MARÍA JOSE; CIARLANTINI, MATIAS S.; MALVICINI, MARIANA; ATORRASAGASTI, CATALINA; GARCIA, MARIANA GABRIELA; ROSSI, MARIO; CAVASOTTO, CLAUDIO; MARTINEZ, ELISABETH; COMIN, JULIETA; MAZZOLINI, GUILLERMO D.
Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma
GUT - AN INTERNATIONAL JOURNAL OF GASTROENTEOROLOGY AND HEPATOLOGY; Año: 2020
MAZZOLINI, GUILLERMO; SOWA, JAN-PETER; ATORRASAGASTI, CATALINA; KÜCÜKOGLU, ÖZLEM; SYN, WING-KIN; CANBAY, ALI
Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
Cells; Año: 2020 vol. 9
MAZZOLINI, GUILLERMO D.; IRACHETA, ALEXIS; MALVICINI, MARIANA; BAYO, JUAN
Immunotherapy for Hepatocellular Carcinoma: Is Latin America Ready for Primetime?
Clinical Liver Disease; Año: 2020 vol. 16 p. 96 - 100
PIÑERO, FEDERICO; TANNO, MARIO; ABALLAY SOTERAS, GABRIEL; TISI BAÑA, MATÍAS; DIRCHWOLF, MELISA; FASSIO, EDUARDO; RUF, ANDRÉS; MENGARELLI, SILVIA; BORZI, SILVIA; FERNÁNDEZ, NORA; RIDRUEJO, EZEQUIEL; DESCALZI, VALERIA; ANDERS, MARGARITA; MAZZOLINI, GUILLERMO; REGGIARDO, VIRGINIA; MARCIANO, SEBASTIÁN; PERAZZO, FLORENCIA; SPINA, JUAN CARLOS; MCCORMACK, LUCAS; MARASCHIO, MARTÍN; LAGUES, CECILIA; GADANO, ADRIÁN; VILLAMIL, FEDERICO; SILVA, MARCELO; CAIRO, FERNANDO; AMEIGEIRAS, BEATRIZ
Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma
ANNALS OF HEPATOLOGY; Año: 2020 vol. 19 p. 546 - 569
ZAPPA VILLAR, MARÍA F.; LÓPEZ HANOTTE, JULIETTE; PARDO, JOAQUÍN; MOREL, GUSTAVO R.; MAZZOLINI, GUILLERMO; GARCÍA, MARIANA G.; REGGIANI, PAULA C.
Mesenchymal Stem Cells Therapy Improved the Streptozotocin-Induced Behavioral and Hippocampal Impairment in Rats
MOLECULAR NEUROBIOLOGY; Año: 2019
LEHMANN, MARIANNE; ZAPPA-VILLAR, MARIA F.; GARCÍA, MARIANA G.; MAZZOLINI, GUILLERMO; CANATELLI-MALLAT, MARTINA; MOREL, GUSTAVO R.; REGGIANI, PAULA C.; GOYA, RODOLFO G.
Umbilical Cord Cell Therapy Improves Spatial Memory in Aging Rats
STEM CELL REVIEWS AND REPORTS; Año: 2019 vol. 15 p. 612 - 617
SUKOWATI, CAECILIA H. C.; ANFUSO, BEATRICE; FIORE, ESTEBAN; IE, SUSAN I.; RASENI, ALAN; VASCOTTO, FULVIA; AVELLINI, CLAUDIO; MAZZOLINI, GUILLERMO; TIRIBELLI, CLAUDIO
Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis
Scientific Reports; Año: 2019 vol. 9
ZAPPA VILLAR, MARIA F.; LEHMANN, MARIANNE; GARCÍA, MARIANA G.; MAZZOLINI, GUILLERMO; MOREL, GUSTAVO R.; CÓNSOLE, GLORIA M.; PODHAJCER, OSVALDO; REGGIANI, PAULA C.; GOYA, RODOLFO G.
Mesenchymal stem cell therapy improves spatial memory and hippocampal structure in aging rats
BEHAVIOURAL BRAIN RESEARCH; Año: 2019 vol. 374
BAYO, JUAN; FIORE, ESTEBAN J.; DOMINGUEZ, LUCIANA M.; REAL, ALEJANDRINA; MALVICINI, MARIANA; RIZZO, MANGLIO; ATORRASAGASTI, CATALINA; GARCÍA, MARIANA G.; ARGEMI, JOSEPMARIA; MARTINEZ, ELISABETH D.; MAZZOLINI, GUILLERMO D.
A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets
JOURNAL OF HEPATOLOGY; Año: 2019
FIORE, ESTEBAN; DOMÍNGUEZ, LUCIANA M.; BAYO, JUAN; MALVICINI, MARIANA; ATORRASAGASTI, CATALINA; RODRIGUEZ, MARCELO; CANTERO, MARÍA JOSÉ; GARCÍA, MARIANA; YANNARELLI, GUSTAVO; MAZZOLINI, GUILLERMO
Human umbilical cord perivascular cells-derived extracellular vesicles mediate the transfer of IGF-I to the liver and ameliorate hepatic fibrogenesis in mice
GENE THERAPY; Año: 2019 vol. 27 p. 62 - 73
RODRÍGUEZ, MARCELO M.; FIORE, ESTEBAN; BAYO, JUAN; ATORRASAGASTI, CATALINA; GARCÍA, MARIANA; ONORATO, AGOSTINA; DOMÍNGUEZ, LUCIANA; MALVICINI, MARIANA; MAZZOLINI, GUILLERMO
4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12
MOLECULAR THERAPY (PRINT); Año: 2018 vol. 26 p. 2738 - 2750
FIORE, ESTEBAN JUAN; DOMÍNGUEZ, LUCIANA MARÍA; BAYO, JUAN; GARCÍA, MARIANA GABRIELA; MAZZOLINI, GUILLERMO DANIEL
Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies
WORLD JOURNAL OF GASTROENTEROLOGY; Año: 2018 vol. 24 p. 2427 - 2440
MAZZOLINI, GUILLERMO DANIEL; BAYO, JUAN
[Epigenetics and hepatocellular carcinoma: ¿a therapeutic opportunity?]
MEDICINA (BUENOS AIRES); Año: 2018
MALVICINI, MARIANA; GUTIERREZ-MORAGA, ANA; RODRIGUEZ, MARCELO M.; GOMEZ-BUSTILLO, SOFIA; SALAZAR, LORENA; SUNKEL, CARLOS; NOZAL, LEONOR; SALGADO, ANTONIO; HIDALGO, MANUEL; LOPEZ-CASAS, PEDRO P.; NOVELLA, JOSE LUIS; VAQUERO, JUAN JOSE; ALVAREZ-BUILLA, JULIO; MORA, ADDA; GIDEKEL, MANUEL; MAZZOLINI, GUILLERMO
A Tricin Derivative from Deschampsia antarctica Desv. Inhibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response
MOLECULAR CANCER THERAPEUTICS; Año: 2018 vol. 17 p. 966 - 976
MAZZOLINI, GUILLERMO; ATORRASAGASTI, CATALINA; ONORATO, AGOSTINA; PEIXOTO, ESTANISLAO; SCHLATTJAN, MARTIN; SOWA, JAN-PETER; SYDOR, SVENJA; GERKEN, GUIDO; CANBAY, ALI
SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
Scientific Reports; Año: 2018 vol. 8
ESTEBAN FIORE; EDUARDO PICAZO; JORGE AQUINO; GUILLERMO MAZZOLINI
CÉLULAS MADRE MESENQUIMALES Y MEDICINA REGENERATIVA EN LA CIRROSIS HEPÁTICA
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2017
FIORE E; MALVICINI M; BAYO J; PEIXOTO E; ATORRASAGASTI C; SIERRA R; RODRIGUEZ M; GOMEZ-BUSTILLO S; GARCIA MG; AQUINO J; MAZZOLINI G
Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
Stem Cell Research and Therapy; Año: 2016
MAZZOLINI G; SOWA J; CANBAY A
Cell death mechanisms in human chronic liver diseases: a far cry from clinical applicability
CLINICAL SCIENCE (LONDON, ENGLAND : 1979); Lugar: Londres; Año: 2016
LUQUE GM; LOPEZ-VICCHY F; ORNSTEIN AM; BRIE B; DE WINNE C; FIORE E; PEREZ MILLAN MI; MAZZOLINI G; RUBINSTEIN M; BECU-VILLALOBOS D
Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine D2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM; Lugar: Bethesda; Año: 2016
KLIONNSKY D; MAZZOLINI G
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
AUTOPHAGY; Lugar: Austin, Texas; Año: 2016
PEIXOTO E; ATORRASAGASTI C; MALVICINI M; FIORE E; RODRIGUEZ M; GARCIA M; FINOCCHIETO ; PODEROSO JJ; CORRALES F; MAZZOLINI G
SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response
Oncotarget; Año: 2016
RIZZO M; ALANIZ L; MAZZOLINI G
Dendritic cell-based therapeutic cancer vaccines
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2016
BAYO J; REAL A; FIORE E; MALVICINI M; SGANGA L; BOLONTRADE M; ANDRIANI O; BIZAMA C; FRESNO C; PODHAJCER O; GIDEKEL M; MAZZOLINI G; GARCIA M
IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.
oncotarget; Año: 2016
PICCIONI F; FIORE E; BAYO J; ATORRASAGASTI C; PEIXOTO E; RIZZO M; MALVICINI M; TIRADO-GONZÁLEZ I; GARCIA MG; ALANIZ L; MAZZOLINI G
4-Methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.
GLYCOBIOLOGY; Lugar: Oxford; Año: 2015
SANMAMED M; LOPEZ RODRIGUEZ I; SCHALPER KA; ONATE C; AZPILIKUETA ; RODRIGUEZ-RUIZ M; MORALES-KASTRESANA A; LABIANO S; PEREZ-GRACIA JL; MARTIN-ALGARRA S; ALFARO C; MAZZOLINI G; SARNO F; HIDALGO M; KORMAN AJ; JURE-KUNKEL M; MELERO I
Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice.
CANCER RESEARCH; Lugar: Philadelphia; Año: 2015
FIORE E; BAYO J; GARCIA MG; MALVICINI M; LLOYD R; PICCIONI F; RIZZO M; PEIXOTO E; SOLA M; ATORRASAGASTI C; ALANIZ L; CAMILLETI MA; ENGUITA M; PRIETO J; AQUINO JB; MAZZOLINI G
Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice.
STEM CELLS AND DEVELOPMENT; Lugar: New York; Año: 2015
PEIXOTO E; ATORRASAGASTI C; AQUINO J; MILITELLO R; BAYO J; FIORE E; PICCIONI F; SALVATIERRA E; ALANIZ L; GARCIA M; BATALLER R; CORRALES F; GIDEKEL M; PODHAJCER O; COLOMBO MI; MAZZOLINI G
SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage.
GENE THERAPY; Lugar: Londres; Año: 2015
MALVICINI M; AQUINO J; MAZZOLINI G
Combined therapy for gastrointestinal carcinomas: exploiting synergies between gene therapy and classical chemo-radiotherapy.
CURRENT GENE THERAPY; Lugar: Oak Park; Año: 2015
FIORE E; MAZZOLINI G; AQUINO J
Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives.
STEM CELL REVIEWS AND REPORTS; Lugar: HEIDELBERG; Año: 2015
MALVICINI M; FIORE E; GHIACCIO V; PICCIONI F; RIZZO M; BONADEO L; GARCIA MG; RODRIGUEZ M; BAYO J; PEIXOTO E; ATORRASAGASTI C; ALANIZ L; AQUINO J; MATAR P; MAZZOLINI G
Tumor microenvironment remodeling by 4-methylumbelliferone boosts the antitumor effect of combined immunotherapy in murine colorectal carcinoma
MOLECULAR THERAPY (PRINT); Lugar: Londres; Año: 2015
RIZZO M; BAYO J; PICCIONI F; MALVICINI M; FIORE E; PEIXOTO E; GARCIA MG; AQUINO JB; GONZALEZ-CAMPANA A; PODESTA LG; TERRES M; ANDRIANI O; ALANIZ L; MAZZOLINI G
Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction
PLOS ONE; Lugar: San Francisco; Año: 2014
BLOIS S; PICCIONI F; FREITAG N; TIRADO-GONZÁLEZ I; MOSCHANSKY P; LLOYD R; HENSEL-WIEGEL K; ROSE M; GARCIA M; ALANIZ L; MAZZOLINI G
Dendritic cells regulate angiogenesis associated with liver fibrogenesis.
ANGIOGENESIS; Lugar: Berlin; Año: 2014 vol. 1 p. 119 - 128
BAYO J; FIORE E; AQUINO J; MALVICINI M; RIZZO M; PEIXOTO E; ANDREANI O; ALANIZ L; PICCIONI F; BOLONTRADE M; PODHAJCER O; GARCIA M; MAZZOLINI G
Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma.
PLOS ONE; Lugar: San Francisco; Año: 2014 vol. 9 p. 95171 - 95181
BAYO J; FIORE E; AQUINO JB; MALVICINI M; RIZZO MM; PEIXOTO E; ALANIZ L; PICCIONI F; BOLONTRADE M; PODHAJCER OL; GARCIA M; MAZZOLINI G
Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor
Biomed Research International; Año: 2014
BIZAMA C; BENAVENTE F; SALVATIERRA E; GUTIERREZ-MORAGA A; ESPINOZA J; FERNANDEZ E; ROA I; MAZZOLINI G; SAGREDO E; GIDEKEL M; PODHAJCER OL
The low-abundance transcriptome reveals novel biomarkers,
INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2014
ALANIZ L; RIZZO M; MAZZOLINI G
Pulsing dendritic cells with whole tumor cell lysates.
METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2014
RIZZO M; ALANIZ L; MAZZOLINI G
Ex vivo loading of autologous dendritic cells with tumor antigens.
METHODS IN MOLECULAR BIOLOGY (CLIFTON, N.J.); Año: 2014
SANMAMED M; CARRANZA-RUA O; ALFARO C; ONATE C; MARTIN-ALGARRA S; PEREZ G; LANDAZURI SF; GONZALEZ A; GROSS S; RODRIGUEZ I; MONOZ-CALLEJA C; RODRIGUEZ-RUIZ M; SANGRO B; LOPEZ-PICAZO JM; RIZZO M; MAZZOLINI G; PASCUAL JI; ANDRUEZA MP; PEREZ-GRACIA JL; MELERO I
Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2014
ATORRASAGASTI C; PEIXOTO E; AQUINO JB; MILITELLO R; BAYO J; FIORE E; PICCIONI F; SALVATIERRA E; ALANIZ L; GARCIA MG; BATALLER R; CORRALES F; GIDEKEL M; PODHAJCER OL; COLOMBO MI; MAZZOLINI G
SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage
GENE THERAPY; Lugar: Londres; Año: 2014
ATORRASAGASTI C; PEIXOTO E; AQUINO JB; KIPPES N; MALVICINI M; ALANIZ L; GARCIA MG; PICCIONI F; FIORE E; BAYO J; BATALLER R; GURUCEAGA E; PODHAJCER OL; MAZZOLINI G
Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice
PLOS ONE; Lugar: San Francisco; Año: 2013 p. 54962 - 54963
OCHOA MC; MAZZOLINI G; HERBAS-STUBBS S; SANMAMED M; BERRAONDO P; MELERO I
Interleukin-15 in gene therapy of cancer.
CURRENT GENE THERAPY; Lugar: Oak Park; Año: 2013 p. 15 - 30
OCHOA MC; FIORAVANTI J; RODRIGUEZ I; HERBAS-STUBBS S; AZPILIKUETA A; MAZZOLINI, G; GURPIDE A; PRIETO J; PARDO J; BERRAONDO P; MELERO I
Antitumor immunotherapeutic and toxic properties of an HDL-conjugated chimeric IL-15 fusion protein.
CANCER RESEARCH; Lugar: Philadelphia; Año: 2013 p. 139 - 149
ARMIANO NO; COSTA MJ; REITERI R; PAYES C; GUERRIERI, D; MAFFIA, PC; DIAMENT M; ORQUEDA, R; ALANIZ L; MAZZOLINI G; SALLENAVE, JM; CHULUYAN, HE
Anti-tumor effect of SLPI on mammary but not colon tumor growth.
JOURNAL OF CELLULAR PHYSIOLOGY; Lugar: New York; Año: 2013 p. 469 - 475
BAYO J; MARRODAN M; AQUINO JB; SILVA M; GARCIA MG; MAZZOLINI G
The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma.
LIVER INTERNATIONAL; Lugar: Londres; Año: 2013
MALVICINI M; PICCIONI F; BAYO J; FIORE E; ATORRASAGASTI C; ALANIZ L; GARCIA, MG; AQUINO JB; GIDEKEL M; MATAR P; GUILLERMO MAZZOLINI
Chemoimmunotherapy for advanced gastrointestinal carcinomas
Oncoimmunology; Año: 2012 p. 1 - 3
BOLONTRADE M; SGANGA L; PIAGGIO E; VIALE DL; SORRENTINO M; ROBINSON A; SEVLEVER G; GARCIA MG; MAZZOLINI G; PODHAJCER OL
A Specific Subpopulation of Mesenchymal Stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus
STEM CELLS AND DEVELOPMENT; Lugar: New York; Año: 2012 p. 2689 - 2702
MAZZOLINI G; OCHOA MC; MORALES-KASTRESANA A; SANMAMED M; MELERO I
The liver, liver metastasis and liver cancer: a special case for immunotherapy with cytokines and immunostimulatory monoclonal antibodies
IMMUNOTHERAPY; Lugar: Londres; Año: 2012 p. 1081 - 1085
PICCIONI F; MALVICINI M; GARCIA MG; RODRIGUEZ A; ATORRASAGASTI C; RIZZO M; AQUINO JB; VIOLA M; MAZZOLINI G
Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.
GLYCOBIOLOGY; Lugar: Oxford; Año: 2012 p. 400 - 410
MALVICINI M; ALANIZ L; BAYO J; GARCIA MG; PICCIONI F; FIORE E; ATORRASAGASTI M; AQUINO JB; MATAR P; GUILLERMO MAZZOLINI
Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
Oncoimmunology; Año: 2012 p. 1 - 10
MALVICINI M; INGOLOTTI M; PICCIONI F; GARCIA MG; BAYO J; ATORRASAGASTI C; ALANIZ L; AQUINO JB; ESPINOZA J; GIDEKEL M; SCHAROVSKY GO; MATAR P; MAZZOLINI G
Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-1
MOLECULAR ONCOLOGY; Lugar: Amsterdam; Año: 2011 p. 242 - 255
ATORRASAGASTI C; AQUINO JB; HOFMAN L; ALANIZ L; MALVICINI M; GARCIA MG; BENEDETTI L; FRIEDMAN S; PODHAJCER OL; MAZZOLINI G
SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDG
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY; Lugar: Bethesda; Año: 2011 p. 739 - 748
LOPEZ ES; RIZZO MM; MAZZOLINI G; GALLO JE
Suramab, a novel antiangiogenic agent, reduces tumor growth and corneal neovascularization.
CANCER CHEMOTHERAPY AND PHARMACOLOGY; Lugar: Berlin; Año: 2011 p. 723 - 728
ALANIZ L; RIZZO MM; GARCIA M; PICCIONI F; AQUINO JB; MALVICINI M; ATORRASAGASTI C; BAYO J; ECHEVERRIA I; SAROBE P; MAZZOLINI G
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma
CANCER IMMUNOLOGY IMMUNOTHERAPY; Lugar: Berlin; Año: 2011 p. 1383 - 1395
GARCIA M; BAYO J; BOLONTRADE M; SGANGA L; MALVICINI M ; ALANIZ L; AQUINO J; FIORE E; RIZZO M ; RODRIGUEZ A; LORENTINI A; ANDREANI O; MAZZOLINI G
Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Mol Pharm; Año: 2011 vol. 8 p. 1538 - 1548
ATORRASAGASTI C, MALVICINI M, AQUINO JB, ALANIZ L, GARCIA M, BOLONTRADE M, RIZZO M, PODHAJCER OL, MAZZOLINI G
Overexpression of SPARC obliterates the in vivo tumorigenicity of human hepatocellular carcinoma cells.
INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Año: 2010 p. 2726 - 2740
SANGRO B; MAZZOLINI G; RUIZ M; RUIZ J; QUIROGA J; HERRERO I; QIAN C; BENITO A; LARRACHE J; OLAGUE C; BOAN J; PEÑUELAS I; SADABA B; PRIETO J
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma
CANCER GENE THERAPY; Lugar: Londres; Año: 2010 p. 837 - 843
AQUINO J, BOLONTRADE M, GARCIA, M, PODHAJCER OL, MAZZOLINI G
Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular
GENE THERAPY; Año: 2010 p. 1 - 17
MALVICINI M; PUCHULO G; MATAR P; MAZZOLINI G
Cancer immunotherapy. Importance of overcoming immune suppression
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2010 p. 565 - 570
ALANIZ L, GARCIA M, RIZZO M, PICCIONI F, MAZZOLINI G
Altered hyaluronan biosynthesis and cancer progression: an immunological perspective.
MINI-REVIEWS IN MEDICINAL CHEMISTRY; Año: 2009 p. 1538 - 1546
CAFFERATA EG; MACCIO DR; LOPEZ MV; VIALE DL; CARBONE C; MAZZOLINI G; PODHAJCER OL
A Novel A33 Promoter-Based Conditionally Replicative Adenovirus Suppresses Tumor Growth and Eradicates Hepatic Metastases in Human Colon Cancer Models
CLINICAL CANCER RESEARCH; Año: 2009 vol. 15 p. 3037 - 3049
ALANIZ L; RIZZO M; MALVICINI M; JAUNARENA J; AVELLA D; ATORRASAGASTI M; AQUINO JB; GARCIA M; MATAR P; SILVA M; MAZZOLINI G
Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response
CANCER LETTERS; Año: 2009 vol. 278 p. 9 - 16
MALVICINI M, RIZZO M, ALANIZ L, PINERO F, GARCIA M, ATORRASAGASTI C, AQUINO JB, ROZADOS V, SCHAROVSKY OG, MATAR P, MAZZOLINI G
A Novel Synergistic Combination of Cyclophosphamide and Gene Transfer of Interleukin-12 Eradicates Colorectal Carcinoma in Mice
CLINICAL CANCER RESEARCH; Año: 2009 p. 7256 - 7265
MATAR P; ALANIZ L; ROZADOS V; AQUINO JB; MALVICINI M; ATORRASAGASTI C; GIDEKEL M; SILVA M; SCHAROVSKY OG; MAZZOLINI G
Immunotherapy for liver tumors: present status and future prospects.
JOURNAL OF BIOMEDICAL SCIENCE; Año: 2009 vol. 6 p. 16 - 30
CAMINO A; ATORRASAGASTI C; MACCIO DR; PRADA F; SALVATIERRA E; RIZZO M; ALANIZ L; AQUINO JB; PODHAJCER OL; SILVA M; MAZZOLINI G
Adenovirus-mediated inhibition of SPARC attenuates liver fibrosis in rats.
JOURNAL OF GENE MEDICINE; Año: 2008 vol. 10 p. 993 - 1004
GUILLERMO MAZZOLINI, OIHANA MURILLO, CATALINA ATORRASAGASTI, JUAN DUBROT, IñIGO TIRAPU,
Immunotherapy and immunoescape in colorectal cancer
WORLD JOURNAL OF GASTROENTEROLOGY; Lugar: Beijing ; Año: 2007 vol. 28 p. 5822 - 5831
OSVALDO L. PODHAJCER, MARÝA VERONICA LOPEZ, GUILLERMO MAZZOLINI
Cytokine gene transfer for cancer therapy.
CYTOKINE & GROWTH FACTOR REVIEWS; Año: 2007 vol. 18 p. 183 - 194
PENUELAS I; MAZZOLINI G; BOAN JF; SANGRO B; MARTI-CLIMENT J; RUIZ M; RUIZ J; SATYAMURTHY N; QIAN C; BARRIO JR; PHELPS ME; RICHTER J; GAMBHIR SS; PRIETO J
Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients.
GASTROENTEROLOGY; Año: 2005 vol. 128 p. 1787 - 1795
MAZZOLINI G; ALFARO C; SANGRO B; FEIJOO E; RUIZ J; BENITO A; TIRAPU I; ARINA A; SOLA J; HERRAIZ M; LUCENA F; SUBTIL J; QUIROGA J; HERRERO I; SADABA B; BENDANDI M; QIAN C; PRIETO J; MELERO I
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.
JOURNAL OF CLINICAL ONCOLOGY; Año: 2005 vol. 23 p. 999 - 1010
SAROBE P; FEIJOO E; ALFARO C; MAZZOLINI G; MELERO I
MAGE antigens: therapeutic targets in hepatocellular carcinoma?
JOURNAL OF HEPATOLOGY; Lugar: Amsterdam; Año: 2004 p. 155 - 158
TIRAPU I; ARINA A; MAZZOLINI G; DUARTE M; ALFARO C; FEIJOO E; QIAN C; CHEN L; PRIETO J; MELERO I
Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens.
INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: New York; Año: 2004 p. 51 - 60
PRIETO J; QIAN C; SANGRO B; MELERO I; MAZZOLINI G
Biologic therapy of liver tumors.
THE SURGICAL CLINICS OF NORTH AMERICA.; Lugar: Philadelphia; Año: 2004 p. 673 - 696
SANGRO B; MAZZOLINI G
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.
JOURNAL OF CLINICAL ONCOLOGY; Año: 2004 p. 1389 - 1397
PENUELAS I; MARTI-CLIMENT J; SANGRO B; MAZZOLINI G; PRIETO J; RITCHER J
Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging.
MOLECULAR IMAGING AND BIOLOGY; Lugar: Berlin; Año: 2004 p. 225 - 238
SANGRO B; MAZZOLINI G
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.
JOURNAL OF CLINICAL ONCOLOGY; Año: 2004 p. 1389 - 1397
PENUELAS I; MARTI-CLIMENT J; SANGRO B; MAZZOLINI G; PRIETO J; RITCHER J
Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging.
MOLECULAR IMAGING AND BIOLOGY; Lugar: Berlin; Año: 2004 p. 225 - 238
MELERO I; GABARI I; TIRAPU I; ARINA A; MAZZOLINI G; BAXEIRAS E; FEIJOO E; ALFARO C; QIAN C; PRIETO J
Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death
CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2003 p. 3546 - 3554
MAZZOLINI G; NARVAIZA I; MARTINEZ-CRUZ LA; ARINA A; BARAJAS M; GALOFRE JC; QIAN C; MATO JM; PRIETO J; MELERO I
Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis
GENE THERAPY.; Lugar: Londres; Año: 2003 p. 1067 - 1078
NARVAIZA I; MAZZOLINI G; BARAJAS M; DUARTE M; ZARATIEGUI M; QIAN C; MELERO I
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy
JOURNAL OF IMMUNOLOGY; Lugar: Bethesda; Año: 2003 p. 3112 - 3122
MURILLO O; ARINA A; TIRAPU I; ALFARO C; MAZZOLINI G; PALENCIA B; LOPEZ-DIAZ DE CERIO A; PRIETO J; BENDANDI M; MELERO I
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies.
CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2003 p. 5454 - 5464
MELERO I; GABARI I; TIRAPU I; ARINA A; MAZZOLINI G; BAXEIRAS E; FEIJOO E; ALFARO C; QIAN C; PRIETO J
Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death
CLINICAL CANCER RESEARCH; Lugar: Philadelphia; Año: 2003 p. 3546 - 3554
MAZZOLINI G; PRIETO J; MELERO I
Gene therapy of cancer with interleukin-12.
CURRENT PHARMACEUTICAL DESIGN.; Lugar: Oak Park; Año: 2003 p. 1981 - 1991
PRIETO J; HERRAIZ M; SANGRO B; QIAN C; MAZZOLINI G; MELERO I; RUIZ J
The promise of gene therapy in gastrointestinal and liver diseases.
GUT - AN INTERNATIONAL JOURNAL OF GASTROENTEOROLOGY AND HEPATOLOGY; Lugar: Londres; Año: 2003 p. 49 - 54
ARINA A; TIRAPU I; ALFARO C; RODRIGUEZ-CALVILLO M; MAZZOLINI G; INOGES S; LOPEZ A; FEIJOO E; BENDANDI M; MELERO I
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming.
EXPERIMENTAL HEMATOLOGY; Lugar: Amsterdam; Año: 2002 p. 1355 - 1364
MAZZOLINI G; SANGRO B; PRIETO J
[In vivo evaluation of gene transfer].
MEDICINA-BUENOS AIRES; Lugar: Buenos Aires; Año: 2002 p. 375 - 376
MELERO I; GABARI I; CORBI AL; RELLOSO M; MAZZOLINI G; SCHMITZ V; RODRIGUEZ-CALVILLO M; TIRAPU I; CAMAFEITA E; AIBAR JP; PRIETO J
An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomas.
CANCER RESEARCH; Lugar: Philadelphia; Año: 2002 p. 3167 - 3174
TIRAPU I; RODRIGUEZ-CALVILLO M; QIAN C; DUARTE M; SMERDOU C; PALENCIA B; MAZZOLINI G; PRIETO J; MELERO I
Cytokine gene transfer into dendritic cells for cancer treatment.
CURRENT GENE THERAPY; Lugar: Oak Park; Año: 2002 p. 79 - 89
TIRAPU I; MAZZOLINI G; RODRIGUEZ-CALVILLO M; ARINA A; PALENCIA B; GABARI I; MELERO I
Effective tumor immunotherapy: start the engine, release the brakes, step on the gas pedal,...and get ready to face autoimmunity
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS; Lugar: BASEL; Año: 2002 p. 13 - 18
RODRIGUEZ-CALVILLO M; DUARTE M; TIRAPU I; BERRAONDO P; MAZZOLINI G; QIAN C; PRIETO J; MELERO I
Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12.
EXPERIMENTAL HEMATOLOGY; Lugar: Amsterdam; Año: 2002 p. 195 - 204
ARINA A; TIRAPU I; ALFARO C; RODRIGUEZ-CALVILLO M; MAZZOLINI G; INOGES S; LOPEZ A; FEIJOO E; BENDANDI M; MELERO I
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming.
EXPERIMENTAL HEMATOLOGY; Lugar: Amsterdam; Año: 2002 p. 1355 - 1364
SCHMITZ V; QIAN C; RUIZ J; SANGRO B; MELERO I; MAZZOLINI G; NARVAIZA I; PRIETO J
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.
GUT - AN INTERNATIONAL JOURNAL OF GASTROENTEOROLOGY AND HEPATOLOGY; Lugar: Londres; Año: 2002 p. 130 - 135
TIRAPU I; RODRIGUEZ-CALVILLO M; QIAN C; DUARTE M; SMERDOU C; PALENCIA B; MAZZOLINI G; PRIETO J; MELERO I
Cytokine gene transfer into dendritic cells for cancer treatment.
CURRENT GENE THERAPY; Lugar: Oak Park; Año: 2002 p. 79 - 89
RODRIGUEZ-CALVILLO M; DUARTE M; TIRAPU I; BERRAONDO P; MAZZOLINI G; QIAN C; PRIETO J; MELERO I
Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12.
EXPERIMENTAL HEMATOLOGY; Lugar: Amsterdam; Año: 2002 p. 195 - 204
MAZZOLINI G; SANGRO B; PRIETO J
[In vivo evaluation of gene transfer].
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2002 p. 375 - 376
BARAJAS M; MAZZOLINI G; GENOVE G; BILBAO R; NARVAIZA I; SCHMITZ V; SANGRO B; MELERO I; QIAN C; PRIETO J
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
HEPATOLOGY (BALTIMORE, MD.); Lugar: New York; Año: 2001 p. 52 - 61
PRIETO J; QIAN C; MELERO I; SANGRO B; MAZZOLINI G; NARVAIZA I; BARAJAS M
Gene therapy of primary and metastatic liver tumors.
MEDICAL SCIENCE MONITOR; Lugar: New York; Año: 2001 p. 76 - 77
MAZZOLINI G; NARVAIZA I; BUSTOS M; DUARTE M; TIRAPU I; BILBAO R; QIAN C; PRIETO J; MELERO I
Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment.
MOLECULAR THERAPY (PRINT); Lugar: Londres; Año: 2001 p. 665 - 672
MELERO I; MAZZOLINI G; NARVAIZA I; QIAN C; CHEN L; PRIETO J
IL-12 gene therapy for cancer: in synergy with other immunotherapies.
TRENDS IN IMMUNOLOGY; Lugar: Amsterdam; Año: 2001 p. 113 - 115
RUIZ J; MAZZOLINI G; SANGRO B; QIAN C; PRIETO J
Gene therapy of hepatocellular carcinoma.
DIGESTIVE DISEASE AND SCIENCES; Lugar: Berlin; Año: 2001 p. 324 - 332
MAZZOLINI G; PRIETO J
[Genetic therapy for the hepatic tumors].
MEDICINA-BUENOS AIRES; Lugar: Buenos Aires; Año: 2001 p. 364 - 368
MAZZOLINI G; RUIZ J; QIAN C; PRIETO J
Gene therapy: its contributions to liver and kidney diseases
NEFROLOGIA; Lugar: Madrid; Año: 2001 p. 17 - 23
BARAJAS M; MAZZOLINI G; GENOVE G; BILBAO R; NARVAIZA I; SCHMITZ V; SANGRO B; MELERO I; QIAN C; PRIETO J
Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.
HEPATOLOGY (BALTIMORE, MD.); Lugar: New York; Año: 2001 p. 52 - 61
PRIETO J; QIAN C; MELERO I; SANGRO B; MAZZOLINI G; NARVAIZA I; BARAJAS M
Gene therapy of primary and metastatic liver tumors.
MEDICAL SCIENCE MONITOR; Lugar: New York; Año: 2001 p. 76 - 77
MAZZOLINI G; NARVAIZA I; PEREZ-DIEZ A; RODRIGUEZ-CALVILLO M; QIAN C; SANGRO B; RUIZ J; PRIETO J; MELERO I
Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.
GENE THERAPY.; Lugar: Londres; Año: 2001 p. 259 - 267
MELERO I; MAZZOLINI G; NARVAIZA I; QIAN C; CHEN L; PRIETO J
IL-12 gene therapy for cancer: in synergy with other immunotherapies.
TRENDS IN IMMUNOLOGY; Lugar: Amsterdam; Año: 2001 p. 113 - 115
RUIZ J; MAZZOLINI G; SANGRO B; QIAN C; PRIETO J
Gene therapy of hepatocellular carcinoma.
DIGESTIVE DISEASE AND SCIENCES; Lugar: Berlin; Año: 2001 p. 324 - 332
MAZZOLINI G; RUIZ J; QIAN C; PRIETO J
Gene therapy: its contributions to liver and kidney diseases
NEFROLOGIA; Lugar: Madrid; Año: 2001 p. 17 - 23
MAZZOLINI G; NARVAIZA I; PEREZ-DIEZ A; RODRIGUEZ-CALVILLO M; QIAN C; SANGRO B; RUIZ J; PRIETO J; MELERO I
Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.
GENE THERAPY; Lugar: Londres; Año: 2001 p. 259 - 267
MAZZOLINI G; PRIETO J
[Genetic therapy for the hepatic tumors].
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2001 p. 364 - 368
MAZZOLINI G; QIAN C; NARVAIZA I; BARAJAS M; BORRAS-CUESTA F; XIE X; DUARTE M; MELERO I; PRIETO J
Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level
HUMAN GENE THERAPY; Lugar: New York; Año: 2000 p. 113 - 125
DRODZIK M; QIAN C; XIE X; PENG D; BILBAO R; MAZZOLINI G; PRIETO J
Combined gene therapy with suicide gene and interleukin-12 is more efficient than therapy with one gene alone in a murine model of hepatocellular carcinoma
JOURNAL OF HEPATOLOGY; Lugar: Amsterdam; Año: 2000 p. 279 - 286
MELERO I; DUARTE M; RUIZ J; SANGRO B; GALOFRE JC; MAZZOLINI G; BUSTOS M; QIAN C; PRIETO J
Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas.
GENE THERAPY; Lugar: Londres; Año: 1999 p. 1779 - 1784
MAZZOLINI G; QIAN C; XIE X; LASARTE JJ; SUN Y; DRODZIK M; PRIETO J
Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12
CANCER GENE THERAPY; Lugar: Londres; Año: 1999 p. 514 - 522
MONTERO A; COHEN J; FERNANDEZ M; MAZZOLINI G; GOMEZ C; PERUGINI J
Cerebral pseudallescheriasis due to Pseudallescheria boydii as the first manifestation of AIDS.
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 1998 p. 1476 - 1477